October 18, 2018

Dr. Balazs Halmos, director, Thoracic Oncology, Montefiore Einstein Center for Cancer Care and director, Clinical Cancer Genomics, Einstein, describes new studies that show combining chemotherapy with immunotherapy may extend the lives of people with metastatic squamous non-small cell lung cancer by more than 40 percent compared with chemotherapy alone—a significant improvement that should immediately change the standard of care

Watch the OncLive Segment